Patents by Inventor ANA BUJ BELLO

ANA BUJ BELLO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders
    Publication number: 20230173102
    Abstract: The invention relates to the use of a recombinant porcine adeno-associated virus (AAV) vector comprising a peptide-modified porcine AAV serotype 1 (AAVpol) capsid in gene therapy of muscle and/or central nervous system (CNS) disorders, in particular neuromuscular diseases such as genetic neuromuscular diseases.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 8, 2023
    Applicants: Genethon, Universität Heidelberg, Universite d'Evry val d'Essonne, Institut National de la Santé et de la Recherche Médicale
    Inventors: Ana Buj Bello, Edith Renaud-Gabardos, Dirk Grimm, Jonas Weinmann
  • VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCY
    Publication number: 20230151390
    Abstract: The present invention relates to a vector comprising an ASAH1 open reading frame, for use in the treatment of acid ceramidase deficiency.
    Type: Application
    Filed: April 14, 2021
    Publication date: May 18, 2023
    Inventors: ANA BUJ BELLO, JÉRÔME DENARD, MARTINA MARINELLO
  • EXPRESSION CASSETTES FOR GENE THERAPY VECTORS
    Publication number: 20220042045
    Abstract: The present invention relates to a recombinant expression cassette comprising a polynucleotide encoding a SMN protein. This cassette can be included in a gene therapy vector and used in a method for the treatment of spinal muscular atrophy (SMA).
    Type: Application
    Filed: December 19, 2019
    Publication date: February 10, 2022
    Inventors: ANA BUJ BELLO, MARTINA MARINELLO
  • TREATMENT OF SPINAL MUSCULAR ATROPHY
    Publication number: 20200370069
    Abstract: The present invention relates to a recombinant adeno-associated virus (rAAV) vector comprising a serotype 9 or rh10 AAV capsid, for use in a method for the treatment of spinal muscular atrophy (SMA).
    Type: Application
    Filed: July 6, 2018
    Publication date: November 26, 2020
    Inventors: ANA BUJ BELLO, MARTINA MARINELLO, SAMIA MARTIN